U.S. Markets close in 4 hrs 49 mins

Valeant Pharmaceuticals International, Inc. (VRX)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
12.83+0.04 (+0.31%)
At close: 4:02PM EDT
People also watch
  • buy VRX and stay away from JCP.
  • VRX will hit 20 $$$$ gor sure
  • JefferyG id's are you going to KILL Papa? your obsession of this pure man is very alarming. You have no interest in vrx yet your whole life is about this man. Simple question will your obsession now lead in you to killing a ceo? Is your hate we read now stop now going to the next degree? If your whole life is to destroy this man and you can't here anymore are you going to KILL him? You have 100's of posts a day talking about how much you hate Papa are you now going to KILL him?
  • For those idiots who know nothing yet keep ranting about how not raising price drugs will bring down VRX, you must be really dumb to believe that. VRX does not need to raise squat. They can make lots money by selling in volume. They even priced the recent drug below market price. During the election everyone was speculating the whole sector would be forced to reduced price by 30% so now it was just speculations. No congressman gives a rashasz what the free market do. In fact, VRX can freely raise the price by 20% each year but they chose not to do so because they don't need that. Papa and his staffs have all the numbers they need to know rather than you so-called analysts only know speculating and get paid by empty full of unchecked fact column
  • Enjoy your nothing life JefferyG id's being a troll saying the same thing over and over can't pay much.
  • saoirsefire is another id from jeffreyG. what a pathetic loser child molester and sex predator idiot
  • It was just mentioned on CNBC that the MV of Bosch and Lomb is greater than all of LTD of VRX. And all bad news behind company. could be a double in near term.
  • luck is another id from the idiot child molester and sex predator jeffreyG.
  • jeffreyG aka child molester and sex predator idiot, go and molest your daughter man. what a pathetic loser
  • jeffreyG is stupid. that article is 4 YEARS OLD. SOLD that a long time ago
  • Gladiator aka bk1elm, go away child molester and sex predator idiot short
  • Gladiator used to be Khaled and med. this is another bs id from saoirsefire and bk1elm. go away child molester and sex predator idiot. what a pathetic loser
  • JefferyG this is what I don't understand you want TTT to stop something you don't like. I can get that but why would you never do the same. People ask you everyday to stop posting the same thing over and over yet you always say no way saying the same thing over and over is your whole life.
  • Gladiator do you not have anyone to spend this weekend with? That really is sad that board is all you really have. Call an old friend get out you have lost it
  • Criminal investigations
    Insider trading investigations
    Shareholder lawsuits
    Patent lawsuits
    Product liability lawsuits
    Generic competition
    Falling top and bottom lines
    Burdensome debt
    Bad reputation

    ....and so on and so forth.
  • Remember Vrx has over 40 new products in it's pipeline.
  • M aka jeffreyG the child molester and sex predator idiot. go away stupid idiot
  • buying AXSM at $4 is like buying JAZZ at $1 a few years ago now trading at $151..PLEASE READ THIS ...
    (AXSM) Market Cap $90 M/Cash $55 M / 5x BIG Phase 3 programs in various indications targeting large Markets with first results in Q3 2017 =20 BAGGER ..FANTASTIC OPPORTUNITY !

    Undiscovered and massive undervalued Biotech Stock with lots of Big News on the way.This Stock is brutally undervalued with a Market cap of just $90 million and $55 million in cash .Founder and Ceo is the larget shareholder holding over 7 million shares (30%) more than 50% of O/S is owned by Insider and Institutions which is a great sign .

    This undiscovered stock could be the next 10 bagger gem if just one of their 5 ongoing Phase 3 programs is successful .GL

    Axsome (AXSM)

    Market-Cap: $90 Million
    Cash: $55 Million(cash runway into the first quarter of 2019.)

    Shares Out: 23.5 Million

    Aegis Capital has reiterated a ‘Buy’ rating and price target of $20 on Axsome Therapeutics (NASDAQ: AXSM) after the company reported financial results for the quarter ended March 31, 2017. The analyst noted that although Axsome reported revenue in-line with consensus estimates, the focus remains on upcoming catalysts such as the company’s ongoing clinical trials. Since February 2017, the company’s AXS-05 has received fast track designation from the FDA for the treatment of Alzheimer’s disease (AD) agitation and treatment resistant depression (TRD). Topline data from the TRD treatment study is expected in the first quarter of 2018. Additionally, Axsome is developing AXS-02 in three separate phase 3 clinical programs, including chronic low back pain associated with modic changes and complex regional pain syndrome, with interim data expected in the fourth quarter of 2017, as well as knee osteoarthritis associated with bone marrow lesions, with interim data expected in the third quarter of 2017.
  • Now you answer a question Glaiator JefferyG where does all you hate come from? How can wake up everyday just to hate it away?
  • Gladiator is another id from bk1elm aka child molester and sex predator idiot